Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Larimar Therapeutics, Inc. | 55,150 | reported | 19 May 2026 | tx 13+958,881 |
| ANNALY CAPITAL MANAGEMENT INC | 45,243 | reported | 14 May 2025 | tx 12+393,835−80,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Larimar Therapeutics, Inc. | 55,150 | 0.00 USD | deriv |
| 27 Feb 2026 | PURCHASE | Larimar Therapeutics, Inc. | 100,000 | 5.00 USD | first after silence |
| 14 May 2025 | GRANT_AWARD | ANNALY CAPITAL MANAGEMENT INC | 8,961 | 0.00 USD | deriv |
| 13 May 2025 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 16 Feb 2024 | PURCHASE | Larimar Therapeutics, Inc. | 57,208 | 8.74 USD | first after silence |
| 29 May 2024 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 15 May 2024 | GRANT_AWARD | ANNALY CAPITAL MANAGEMENT INC | 8,583 | 0.00 USD | deriv |
| 17 May 2023 | GRANT_AWARD | ANNALY CAPITAL MANAGEMENT INC | 8,167 | 0.00 USD | deriv |
| 09 May 2023 | GRANT_AWARD | Larimar Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 16 Sept 2022 | PURCHASE | Larimar Therapeutics, Inc. | 317,460 | 3.15 USD | first after silence |
| 18 May 2022 | GRANT_AWARD | ANNALY CAPITAL MANAGEMENT INC | 24,372 | 0.00 USD | deriv |
| 10 May 2022 | GRANT_AWARD | Larimar Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 30 Jun 2021 | PURCHASE | Larimar Therapeutics, Inc. | 56,710 | 8.75 USD | first after silence |
| 19 May 2021 | GRANT_AWARD | ANNALY CAPITAL MANAGEMENT INC | 15,609 | 0.00 USD | deriv |
| 12 May 2021 | GRANT_AWARD | Larimar Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 03 May 2021 | SALE | ANNALY CAPITAL MANAGEMENT INC | 80,000 | 9.18 USD | |
| 29 Sept 2020 | GRANT_AWARD | Larimar Therapeutics, Inc. | 16,600 | 0.00 USD | deriv |
| 26 Jun 2020 | OTHER | Larimar Therapeutics, Inc. | 159,433 | 0.00 USD | |
| 26 Jun 2020 | OTHER | Larimar Therapeutics, Inc. | 133,420 | 0.00 USD | |
| 20 May 2020 | GRANT_AWARD | ANNALY CAPITAL MANAGEMENT INC | 22,551 | 0.00 USD | deriv |
| 15 May 2020 | PURCHASE | ANNALY CAPITAL MANAGEMENT INC | 200,000 | 5.96 USD | |
| 22 May 2019 | GRANT_AWARD | ANNALY CAPITAL MANAGEMENT INC | 15,592 | 0.00 USD | deriv |
| 17 May 2019 | PURCHASE | ANNALY CAPITAL MANAGEMENT INC | 30,000 | 9.47 USD | |
| 17 May 2019 | PURCHASE | ANNALY CAPITAL MANAGEMENT INC | 30,000 | 9.47 USD | |
| 17 May 2019 | PURCHASE | ANNALY CAPITAL MANAGEMENT INC | 30,000 | 9.47 USD |
4 purchases reported after at least 12 months of silence — most recent on 27 Feb 2026.